|
|
| | Volvaltrate B Basic information |
| Product Name: | Volvaltrate B | | Synonyms: | Volvaltrate B;Valtrate J;Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, [(1S,4aR,6S,7S,7aS)-6-(acetyloxy)-7-(chloromethyl)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-1-(3-methyl-1-oxobutoxy)cyclopenta[c]pyran-4-yl]methyl ester, (2R)- | | CAS: | 1181224-13-4 | | MF: | C27H41ClO11 | | MW: | 577.06 | | EINECS: | | | Product Categories: | | | Mol File: | 1181224-13-4.mol |  |
| | Volvaltrate B Chemical Properties |
| Boiling point | 632.3±55.0 °C(Predicted) | | density | 1.26±0.1 g/cm3(Predicted) | | pka | 11.14±0.70(Predicted) |
| | Volvaltrate B Usage And Synthesis |
| Uses | Volvaltrate B is an anticancer agent, iridoid, can be obtained from the root of valerian (Valeriana officinalis). Volvaltrate B is effective against ovarian tumors in female mice. Volvaltrate B has the potential to study cancer[1][2]. | | References | [1] Tan YZ, et al. Iridoids from Valeriana jatamansi induce autophagy-associated cell death via the PDK1/Akt/mTOR pathway in HCT116 human colorectal carcinoma cells. Bioorg Chem. 2019 Jun;87:136-141. DOI:10.1016/j.bioorg.2019.03.020
[2] Wang PC, et al. Iridoids and sesquiterpenoids from the roots of Valeriana officinalis. J Nat Prod. 2009 Sep;72(9):1682-5. DOI:10.1021/np9003382 |
| | Volvaltrate B Preparation Products And Raw materials |
|